SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6.47 |
| Enterprise Value ($M) | 3.23 |
| Book Value ($M) | 8.85 |
| Book Value / Share | 3.48 |
| Price / Book | 0.73 |
| NCAV ($M) | 3.50 |
| NCAV / Share | 1.37 |
| Price / NCAV | 1.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.27 |
| Return on Equity (ROE) | -0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.83 |
| Current Ratio | 5.83 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.22 |
| Assets | 9.57 |
| Liabilities | 0.72 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.00 |
| Operating Income | -3.63 |
| Net Income | -3.06 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -4.33 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Hecht Peter M | 27.90 | 22.26 | |
| 13G/A | American Endowment Foundation | 4.91 | -95.00 | |
| 13G/A | Fmr Llc | 0.20 | -97.09 | |
| 13G/A | Slate Path Capital LP | 0.00 | -100.00 | |
| 13G/A | Artal International S.C.A. | 4.30 | -16.41 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,293 | 16,779 | 7.71 | |
| 5,833 | 11,617 | 50.21 | |
| 16,300 | 23,372 | 69.74 | |
| 2,322 | 12,596 | 18.43 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CUE – Cue Biopharma, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
| CYCC – Cyclacel Pharmaceuticals, Inc. | CYRX – Cryoport, Inc. |
| DARE – Daré Bioscience, Inc. |
Financial data and stock pages provided by
Fintel.io